Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Vector Shedding and Blood Biodistribution in Patients with Severe Hemophilia a Following Administration of Valoctocogene Roxaparvovec

Annie Clark, PhDPharmD, Kevin Hammon, Krystal Sandza, Richard Torres, Elli Koziol, Jennifer Holcomb, Benjamin Kim, MD, Kala Jayaram, MD, Chris Russell, PhD, Christian Vettermann, PhD, Joshua Henshaw, PhD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-136459

Published: 2020

Journal Articles

The Spectrum of Amino Acid Substitutions Resulting from Single Nucleotide Substitutions in the Coagulation Biosystem: Impact on Identification By Mass Spectrometry

Kevin R. Viel, PhD, Benjamin Kim, MD MPhil, Maria Elizabeth Tejero, PhD, Shelley S. Cole, PhD, Tom E. Howard, MD PhD, Amparo Santamaría Ortiz, MD, PhD

Blood (2014) 124 (21): 4221.

https://doi.org/10.1182/blood.V124.21.4221.4221

Published: 2014

Journal Articles

Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism

Wendy Hsiao, BS, Thomas Delate, PhD MS, Daniel M Witt, PharmD, Melissa R Meyer, PharmD, Alan Go, MD, Margaret Fang, MD MPH, Benjamin Kim, MD MPhil

Blood (2014) 124 (21): 3513.

https://doi.org/10.1182/blood.V124.21.3513.3513

Published: 2014

Journal Articles

Regional Differences in Patient-Reported Outcomes in a Study of Adult Prophylaxis Versus on-Demand Treatment with Bayer’s Sucrose-Formulated Recombinant Factor VIII: 3-Year Data from Spinart

Jennifer Pocoski, PharmD, Benjamin Kim, MD MPhil, Thomas J. Humphries, MD, Walter Hong

Blood (2014) 124 (21): 1518.

https://doi.org/10.1182/blood.V124.21.1518.1518

Published: 2014

Journal Articles

No Evidence of Cis -Acting SNPs In Immune Response Genes Previously Associated with Factor VIII Inhibitors: The San Antonio Family Heart Study

Tom E. Howard, M.D., Ph.D., Kevin R. Viel, Ph.D., Eugene Drigalenko, Ph.D., Shelley Cole, Ph.D., Melinda Epstein, Ph.D., Melanie Carless, Ph.D., Richard Hughes, Ph.D., Benjamin Kim, MD, Tom Dyer, M.S., Kathleen P. Pratt, PhD, Jean W. MacCluer, Ph.D., Joanne E. Curran, Ph.D., Matthew P. Johnson, Ph.D., Eric K. Moses, Ph.D., John Blangero, Ph.D., Laura Almasy, Ph.D., Harald Göring, Ph.D.

Blood (2010) 116 (21): 4422.

https://doi.org/10.1182/blood.V116.21.4422.4422

Published: 2010

Journal Articles

The Role of Immune-Response Gene Variants in Inhibitor Development in Black Patients with Hemophilia A.

Tom E. Howard, MD, PhD, Shelley A. Cole, PhD, Carol K. Kasper, MD, Afshin Ameri, MD, Kavita Natarajan, MD, Raymond G. Watts, MD, Valrie A. Manard, RN, Shelley M. Nakaya, Christine L Kempton, MD, MSc, Martina Kennedy, DO, Benjamin Kim, MD, Rathi V. Iyer, MD, Laura Almasy, PhD

Blood (2009) 114 (22): 1301.

https://doi.org/10.1182/blood.V114.22.1301.1301

Published: 2009

Journal Articles

Erythropoiesis Stimulating Agent (ESA) Use for Anemic Cancer and Chronic Kidney Disease (CKD) Patients in 2008: Advocacy for Conservative Use

Charles L. Bennett, MD, PhD, MPP, Benjamin Kim, MD, Athena T Samaras, BA, Allen R Nissenson, MD, FACP, A. Oliver Sartor, MD, D. Mark Courtney, MD, Robert I. Liem, MD, Dennis P West, PhD, Simone N Boyle, BA, Robin L Wagner, Carolyn E Goldstein, Steven M Trifilio, RPh, David M Spiegel, MD, FACP, Stephen Y Lai, MD, PhD

Blood (2008) 112 (11): 4680.

https://doi.org/10.1182/blood.V112.11.4680.4680

Published: 2008

Journal Articles

Evaluating Mortality with Erythropoietin Stimulating Agents (ESAs) in the Oncology Setting: The Importance of Selecting Trials That Include Survival or Loco-Regional Tumor Control as a Primary Endpoint

Athena T Samaras, BA, Sara E Barnato, MD, Benjamin Kim, MD, Stephen Y Lai, MD, PhD, A. Oliver Sartor, MD, June McKoy, MD, JD, MPH, Brian C Sauer, PhD, Charles L. Bennett, MD, PhD, MPP

Blood (2008) 112 (11): 4681.

https://doi.org/10.1182/blood.V112.11.4681.4681

Published: 2008

Journal Articles

Pancreatitis Preceding Acute Episodes of Thrombotic Thrombocytopenic Purpura: Report of Five Patients with a Systematic Review of Published Reports.

Karen K. Swisher, MD, John T. Doan, MD, Sara K. Vesely, PhD, Hau C. Kwaan, MD, PhD, Benjamin Kim, MD, Bernhard Lammle, MD, Johanna Kremer Hovinga, MD, James N. George, MD

Blood (2006) 108 (11): 1058.

https://doi.org/10.1182/blood.V108.11.1058.1058

Published: 2006

Journal Articles

ADAMTS13 Levels Support Hypothesis of Distinct Mechanistic Pathways for Early Versus Late-Onset of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP).

H.C. Kwaan, MD, PhD, June M. McKoy, MD, MPH, JD, Kathryn R. McCaffrey, BA, Paul R. Yarold, PhD, Benjamin Kim, MD, Anaadriana Zakarija, MD, Nicholas Bandarenko, MD, Dilip K. Pandey, MD, PhD, James N. George, MD, X. Long Zheng, MD, PhD, Kenneth R. Carson, MD, Charles L. Bennett, MD, PhD, MPP

Blood (2005) 106 (11): 60.

https://doi.org/10.1182/blood.V106.11.60.60

Published: 2005

Journal Articles

Long-Term Follow-Up of Recombinant Human Erythropoietin (epoetin)Induced Pure Red Cell Aplasia (PRCA): A Comparison of Data Collected through Active and Passive Pharmacovigilance Efforts.

Charles L. Bennett, MD, PhD, Kenneth R. Carson, MD, June M. McKoy, MD, JD, MPH, Steven M. Belknap, MD, Stephen A. Klinge, BA, Andrew M. Evens, MD, Dennis W. Raisch, PhD, Paul R. Yarnold, PhD, Benjamin Kim, MD, Elizabeth A. Lyons, BA, Timothy K. Kuzel, MD, Martin S. Tallman, MD

Blood (2004) 104 (11): 5319.

https://doi.org/10.1182/blood.V104.11.5319.5319

Published: 2004

Journal Articles

Are There Two Distinct Mechanistic Pathways That Explain the Varying Clinical Presentations, Laboratory Findings, and Outcomes of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP)?.

Benjamin Kim, MD, Kenneth R. Carson, MD, Kathryn McCaffrey, BA, Denise Finley, Anaadriana Zakarija, MD, Nicholas Bandarenko, MD, Dilip K. Pandey, MBBS, MS, PhD, Dennis W. Raisch, PhD, Hau C. Kwaan, MD, PhD, Paul R. Yarnold, PhD, Charles L. Bennett, MD, PhD, MPP

Blood (2004) 104 (11): 860.

https://doi.org/10.1182/blood.V104.11.860.860

Published: 2004

Journal Articles

Long-Term Follow-Up of 98 Cases of Recombinant Human Erythropoietin (epoetin) Induced Pure Red Cell Aplasia (PRCA): Outcomes and Treatment Data from the Research on Adverse Drug Reactions and Reports (RADAR) Program.

Kenneth R. Carson, MD, Stephen A. Klinge, BA, Steven M. Belknap, MD, June M. McKoy, MD, JD, MPH, Dennis W. Raisch, PhD, Martin S. Tallman, MD, Timothy M. Kuzel, MD, Andrew M. Evans, MD, Benjamin Kim, MD, Paul R. Yarnold, PhD, Elizabeth A. Lyons, BA, Charles L. Bennett, MD, PhD

Blood (2004) 104 (11): 5320.

https://doi.org/10.1182/blood.V104.11.5320.5320

Published: 2004

NARROW

Vector Shedding and Blood Biodistribution in Patients with Severe Hemophilia a Following Administration of Valoctocogene Roxaparvovec

The Spectrum of Amino Acid Substitutions Resulting from Single Nucleotide Substitutions in the Coagulation Biosystem: Impact on Identification By Mass Spectrometry

Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism

Regional Differences in Patient-Reported Outcomes in a Study of Adult Prophylaxis Versus on-Demand Treatment with Bayer’s Sucrose-Formulated Recombinant Factor VIII: 3-Year Data from Spinart

No Evidence of Cis -Acting SNPs In Immune Response Genes Previously Associated with Factor VIII Inhibitors: The San Antonio Family Heart Study

The Role of Immune-Response Gene Variants in Inhibitor Development in Black Patients with Hemophilia A.

Erythropoiesis Stimulating Agent (ESA) Use for Anemic Cancer and Chronic Kidney Disease (CKD) Patients in 2008: Advocacy for Conservative Use

Evaluating Mortality with Erythropoietin Stimulating Agents (ESAs) in the Oncology Setting: The Importance of Selecting Trials That Include Survival or Loco-Regional Tumor Control as a Primary Endpoint

Pancreatitis Preceding Acute Episodes of Thrombotic Thrombocytopenic Purpura: Report of Five Patients with a Systematic Review of Published Reports.

ADAMTS13 Levels Support Hypothesis of Distinct Mechanistic Pathways for Early Versus Late-Onset of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP).

Long-Term Follow-Up of Recombinant Human Erythropoietin (epoetin)Induced Pure Red Cell Aplasia (PRCA): A Comparison of Data Collected through Active and Passive Pharmacovigilance Efforts.

Are There Two Distinct Mechanistic Pathways That Explain the Varying Clinical Presentations, Laboratory Findings, and Outcomes of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP)?.

Long-Term Follow-Up of 98 Cases of Recombinant Human Erythropoietin (epoetin) Induced Pure Red Cell Aplasia (PRCA): Outcomes and Treatment Data from the Research on Adverse Drug Reactions and Reports (RADAR) Program.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only